{"id":46793,"date":"2022-08-01T15:01:55","date_gmt":"2022-08-01T13:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/"},"modified":"2022-08-01T15:01:55","modified_gmt":"2022-08-01T13:01:55","slug":"syntellis-performance-solutions-completes-acquisition-of-stratasan","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/","title":{"rendered":"Syntellis Performance Solutions Completes Acquisition of Stratasan\u00a0"},"content":{"rendered":"
\n

\nDelivering unparalleled intelligence and insights to help healthcare leaders strategically determine where, when, and how to grow\n<\/p>\n

CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions<\/a>, the leading provider of enterprise performance management software, data and intelligence solutions, today announced it has completed the acquisition of Stratasan, an industry leader in advanced healthcare market intelligence and data analytics. Syntellis announced<\/a> its intent to acquire Stratasan on July 11.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWe are thrilled to welcome the Stratasan team to Syntellis,\u201d said Flint Brenton, CEO of Syntellis. \u201cBy adding Stratasan\u2019s powerful strategic growth capabilities to our suite of intelligent planning and performance products, Syntellis will empower more healthcare organizations with best-in-class data and intelligence solutions to improve operational, financial and strategic growth planning so they can ensure future success and stability.\u201d\n<\/p>\n

\nTogether, the combination of Syntellis and Stratasan data and intelligence solutions will deliver unparalleled insights to healthcare leaders and create the industry\u2019s most robust set of tools designed to help providers and other healthcare organizations strategically determine where, when and how to grow.\n<\/p>\n

\nThis acquisition reinforces Syntellis\u2019 focus on innovation and growth, providing podium products and its strong commitment to connecting operational, financial, and strategic data so customers can grow strategically, strengthen service to their communities, and improve outcomes in an ever-changing healthcare environment.\n<\/p>\n

\nAbout Syntellis Performance Solutions<\/b>\n<\/p>\n

\nSyntellis Performance Solutions provides innovative enterprise performance management software, data and intelligence solutions for healthcare, higher education and financial institutions. Syntellis\u2019 solutions include Axiom and Connected Analytics software, which help finance professionals elevate performance by acquiring insights, accelerating decisions and advancing their business plans. With over 2,800 organizations and 450,000 users relying on its solutions, Syntellis has proven industry expertise in helping organizations transform their visions into reality. For more information, please visit www.syntellis.com<\/a>.\n<\/p>\n

\nLinkedIn: Syntellis Performance Solutions<\/a>
<\/b>Twitter: @Syntellis<\/a><\/b>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nCam Granstra
\n
Syntellis Performance Solutions
\n
872-246-6358
\n
CGranstra@syntellis.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Delivering unparalleled intelligence and insights to help healthcare leaders strategically determine where, when, and how to grow CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced it has completed the acquisition of Stratasan, an industry leader in advanced healthcare market intelligence and data analytics. Syntellis announced … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46793","6":"format-standard","7":"category-industry"},"yoast_head":"\nSyntellis Performance Solutions Completes Acquisition of Stratasan\u00a0 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syntellis Performance Solutions Completes Acquisition of Stratasan\u00a0 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Delivering unparalleled intelligence and insights to help healthcare leaders strategically determine where, when, and how to grow CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced it has completed the acquisition of Stratasan, an industry leader in advanced healthcare market intelligence and data analytics. Syntellis announced ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-01T13:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220801005244\/en\/1530068\/21\/Syntellis_Performance_Solutions_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Syntellis Performance Solutions Completes Acquisition of Stratasan\u00a0\",\"datePublished\":\"2022-08-01T13:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/\"},\"wordCount\":312,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220801005244\\\/en\\\/1530068\\\/21\\\/Syntellis_Performance_Solutions_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/\",\"name\":\"Syntellis Performance Solutions Completes Acquisition of Stratasan\u00a0 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220801005244\\\/en\\\/1530068\\\/21\\\/Syntellis_Performance_Solutions_Logo.jpg\",\"datePublished\":\"2022-08-01T13:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220801005244\\\/en\\\/1530068\\\/21\\\/Syntellis_Performance_Solutions_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220801005244\\\/en\\\/1530068\\\/21\\\/Syntellis_Performance_Solutions_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-completes-acquisition-of-stratasan\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syntellis Performance Solutions Completes Acquisition of Stratasan\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syntellis Performance Solutions Completes Acquisition of Stratasan\u00a0 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/","og_locale":"en_US","og_type":"article","og_title":"Syntellis Performance Solutions Completes Acquisition of Stratasan\u00a0 - Pharma Trend","og_description":"Delivering unparalleled intelligence and insights to help healthcare leaders strategically determine where, when, and how to grow CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced it has completed the acquisition of Stratasan, an industry leader in advanced healthcare market intelligence and data analytics. Syntellis announced ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-01T13:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220801005244\/en\/1530068\/21\/Syntellis_Performance_Solutions_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Syntellis Performance Solutions Completes Acquisition of Stratasan\u00a0","datePublished":"2022-08-01T13:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/"},"wordCount":312,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220801005244\/en\/1530068\/21\/Syntellis_Performance_Solutions_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/","url":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/","name":"Syntellis Performance Solutions Completes Acquisition of Stratasan\u00a0 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220801005244\/en\/1530068\/21\/Syntellis_Performance_Solutions_Logo.jpg","datePublished":"2022-08-01T13:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220801005244\/en\/1530068\/21\/Syntellis_Performance_Solutions_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220801005244\/en\/1530068\/21\/Syntellis_Performance_Solutions_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-completes-acquisition-of-stratasan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Syntellis Performance Solutions Completes Acquisition of Stratasan\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46793"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46793\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}